For decades, the demand to ensure a quality environment for healthcare workers and patients has been a highly discussed topic. USP General Chapter <800>, a regulation implemented on December 1, 2019, addresses the safe handling of hazardous drugs to minimize the risk of exposure to healthcare personnel, patients, and the environment. 1
The National Institute for Occupational Safety and Health (NIOSH) considers a drug to be hazardous if it exhibits one or more of the following characteristics in humans or animals: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or structure and toxicity profiles of new drugs that mimic existing hazardous drugs. 2 USP <800> standards and procedures will eliminate the potential risk posed to patients and the healthcare workforce. 2
In 2018, about 8 million U.S. healthcare workers—including pharmacy and nursing staffs, clinicians, operating room personnel, environmental workers, research laboratories, and veterinary care employees—were exposed to precarious drugs. 2
Handling hazardous drugs can result in life-threatening health effects for the healthcare labor force. The Centers for Disease Control and Prevention reports workplace exposures to lethal medications can cause both acute and chronic health effects such as skin rashes, adverse reproductive outcomes (including infertility, spontaneous abortions, and congenital malformations), and leukemia and other cancers. 2
Follow the guidelines below to ensure your facility is USP <800> compliant 3
With this new ruling, all personnel handling, administering, or transporting any hazardous drugs within a medical facility must abide by the USP <800> regulation. Henry Schein’s vast portfolio of products and solutions can easily transition your practice to meet the USP <800> ruling requirements.